ABSTRACT
INTRODUCTION
General Anaesthesia (GA) is considered the anaesthetic technique of choice for laparoscopic procedures including laparoscopic gynaecological procedures. Regional anaesthesia as a sole technique was initially advocated for cases who were considered high-risk candidates for general anaesthesia. [1, 2] However, nowadays, it is also opted as a routine technique for healthy patients. [3, 4] Studies have demonstrated that surgeries like laparoscopic cholecystectomy can be safely performed under spinal anaesthesia. [5] However, anxiety and other problems related to pneumoperitoneum like shoulder tip pain causes discomfort to the patients during these procedures under spinal anaesthesia. These problems can be overcome by providing proper sedation during the procedure.
Dexmedetomidine is a selective α2-adrenoreceptor agonist, which has sedative, analgesic, anxiolytic properties with preservation of the ventilatory drive. [6] Also, intravenous dexmedetomidine administration with spinal anaesthesia has been said to prolong the effects of the sensory and motor block along with a sedative effect. [7] Pentazocine is a mixed agonist-antagonist analgesic with agonistic action at κ and σ receptors and a weak antagonistic action at μ receptor. Pentazocine is a benzomorphan derivative. It alters perception of and response to pain and produces generalised CNS depression by binding to opiate receptors in the CNS and acting as a partial agonist/antagonist.
Although, there are a number of studies on laparoscopic cholecystectomy and appendicectomy under spinal anaesthesia. Very few studies have been reported on laparoscopic gynaecological procedures under spinal anaesthesia. In our study, we intended to analyse the feasibility of performing laparoscopic gynaecological procedures of short duration under spinal anaesthesia along with dexmedetomidine infusion for sedation and pentazocine injection as a rescue sedative and analgesic if required. Upon the patient's arrival in the operating room, standard routine monitoring including noninvasive automated blood pressure, pulse oximetry, and electrocardiography was started. Oxygen was administered at 6 L/min via a facemask and EtCO2 was monitored throughout the procedure. Under all strict aseptic and antiseptic precaution with the patient in left lateral position, lumbar puncture was performed at L2-L3 intervertebral space with 25G Quincke needle and 1.6 mL of 5% lignocaine was given slowly after free flow of clear CSF was obtained. After completion of the procedure, patient was immediately turned to supine position. A 10 0 head down tilt was maintained for 10 minutes allowing the drug to fix. In these 10 minutes, a loading dose of dexmedetomidine 1 µgm/kg was infused. Level of sensory block was confirmed. During the surgery, continuous dexmedetomidine infusion at a rate of 0.5 µgm/kg/hr was given and patient's discomfort if any like shoulder tip pain, abdominal discomfort, anxiety, etc. was managed by pentazocine injection (15 mg).
MATERIALS AND METHODS
The sensory block level was assessed by the pinprick test using a 24-gauge hypodermic needle while the motor block level was assessed by the modified Bromage scale (0=no paralysis; 1=unable to raise extended leg; 2=unable to flex knee; 3=unable to flex ankle) and recorded 10 min. after placement in the supine position. The level of sedation was evaluated immediately before dexmedetomidine loadingdose infusion (baseline) and at 5 mins., 15 mins., 25 mins. from the starting of the procedure and one at the end of the surgery using the Ramsay sedation score. Hypotension was defined as a 20% decrease from the baseline systolic blood pressure and was treated primarily with intravenous crystalloid fluid and 6 mg mephentermine bolus intravenously. Bradycardia was defined as a heart rate of less than 60 beats per minute and was treated with 0.6 mg of intravenous atropine. Adverse effects like referred shoulder pain, abdominal discomfort, hypotension, nausea were recorded. Postoperative pain scores were assessed at 1, 3, 6, 12, and 24 hours postoperatively using a 0 to 10 cm visual analogue scale (0=no pain, 10=worst pain imaginable).
The overall level of patient satisfaction was also assessed using a four point scale (Excellent, good, average, and poor) on the first postoperative day.
RESULTS AND OBSERVATIONS
The procedures included in the study includes diagnostic laparoscopies (25 out of 60), laparoscopic tubal occlusion (20 out of 60), and laparoscopic ovarian drilling (15 out of 60). The demographic data of the patients included in the study are summarised in Table 1 . A sensory level of T3, T4, T5, and T6 was obtained in 5, 38, 12, and 5 patients respectively as shown in Fig. 1 . A modified Bromage scale score of 3, 2 was achieved in 38 and 22 patients respectively and is shown in Fig. 2 . The mean operative duration was 35.4±3.2 min. The mean duration of anaesthesia was 65.8±4.6 mins. During the operation, the intra-abdominal CO2 gas pressure was maintained at 12 and 14 mmHg in 39 and 21 patients, respectively. Adverse effects observed during surgery are summarised in Table 2 . 
Data are expressed as numbers of patients (%).
Patients who complained of referred shoulder pain and abdominal discomfort were relieved after giving inj. pentazocine 15 mg in 19 patients and in 5 cases repeat injection of another 15 mg pentazocine was required to relieve the discomfort.
Hypotension occurred in sixteen patients who were treated primarily with intravenous fluids. In patients whose blood pressure were not responsive to fluid administration, inj. mephentermine was used. 7 of the patients responded to 6 mg mephentermine and 4 patients had to be given 2 doses of 6 mg mephentermine (i.e. 12 mg). Bradycardia occurred in sixteen patients all of whom were corrected by 0.6 mg of atropine. None of the patients complained of nausea. There was no incidence of vomiting or respiratory depression in any of the patients.
None of the patients required conversion to general anaesthesia or conversion to open surgery. The Ramsay sedation score of the patients at 5 mins, 15 mins, and 25 mins from the start of the procedure and at the end of surgery are summarised in Fig. 3 .
Fig. 3
The postoperative pain score was 1.8±1.5, 2.8±2.2, 2.2±1.3, 1.2±1.0, 0.8±0.9 at 1 hr., 3 hrs., 6 hrs., 12 hrs., and 24 hrs. postoperative and it was satisfactory and is summarised in table 3. The degree of patient satisfaction was excellent, good, average, and poor in 8, 19, 29, and 4 patients, respectively.
Time (Postoperative)
Mean Postoperative Pain Score (VAS) 1 hr.
1.8±1.5 3 hrs.
2.8±2.2 6 hrs.
2.2±1.3 12 hrs.
1.2±1.0 24 hrs. 0.8±0.9 Table 3 DISCUSSION In this study, gynaecological laparoscopic procedures of short duration were done under spinal anaesthesia along with continuous intravenous dexmedetomidine infusion. There was referred shoulder pain and abdominal discomfort in 24 and 10 patients, respectively, but were managed with injection pentazocine. Bradycardia and hypotension were observed in 16 patients each. None of the cases were converted to general anaesthesia or open surgery.
Shoulder tip pain, abdominal discomfort, and anxiety during intra-abdominal carbon dioxide pneumoperitoneum for laparoscopic procedures and their proper management is a major concern during the use of spinal anaesthesia in these cases. Amongst all the discomforts, carbon dioxide pneumoperitoneum-induced shoulder pain during laparoscopic surgery under spinal anaesthesia is the most distressing. Postoperative shoulder tip pain after general anaesthesia is easily managed by removing intra-abdominal residual carbon dioxide by applying active aspiration via the trocars [8] or by lung recruitment manoeuvre. [9] However, intraoperative shoulder tip pain during regional anaesthesia is a leading cause of conversion to general anaesthesia. [10, 11] Carbon dioxide gas insufflations in the abdomen and the head-down tilt position causes abdominal discomfort and referred shoulder tip pain. [12] In order to minimise these discomforts, dexmedetomidine infusion was used. The analgesic and sedative effects of dexmedetomidine were expected to resolve the pain and discomfort during the carbon dioxide pneumoperitoneum without causing respiratory depression. Intravenous dexmedetomidine infusion was given till the intra-abdominal carbon dioxide gas was deflated. In this study, intravenous pentazocine (15 mg) is used as a supplement for its sedative as well as analgesic effect.
Dexmedetomidine as well as spinal anaesthesia are both commonly associated with adverse effects like hypotension and bradycardia. In a phase-III study of 401 patients, the incidence of hypotension and bradycardia associated with dexmedetomidine were 30% and 9%, respectively. [13] The incidence of hypotension increases with an increase in the dose of dexmedetomidine [14] whereas the incidence of bradycardia is not related to the increase in the dose of dexmedetomidine. Some studies have also shown that dexmedetomidine use during spinal anaesthesia is associated more frequently with bradycardia than hypotension. [7] At intra-abdominal pressures of <15 mmHg, venous return, cardiac filling pressure, and cardiac output are increased as blood is squeezed from the splanchnic circulation as well as by peripheral vasoconstriction. [15] The insertion of the Veress needle or trocar and the peritoneal stretching caused by pneumoperitoneum can cause vagal stimulation thereby causing bradycardia. [16] In this study, none of the patients complained of nausea and there was no incidence of vomiting in any of the patients, which correlates with the study of Sinclair et al [17] who found that there was an 11-fold decreased risk for nausea and vomiting in patients receiving regional anaesthesia as compared with those receiving general anaesthesia.
Further studies have to be done by including larger number of patients and with a comparison group or a placebo. Moreover, the effects of various maintenance doses of dexmedetomidine (0.2-0.7 µg/kg/hr.) need to be evaluated to calculate the optimum maintenance dose.
In conclusion, this study has shown that spinal anaesthesia with dexmedetomidine infusion maybe used for short gynaecological laparoscopic procedure thereby avoiding intubation and its associated complications. There is however always a need of supplemental analgesia, sedation, and careful monitoring during the procedure.
